Sickle Cell Anemia Testing & Screening Market was valued at USD 0.83 Billion in 2022 and is projected to reach USD 1.45 Billion by 2030, growing at a CAGR of 7.3% from 2024 to 2030.
During the 2018 to 2022 period, significant strides were made in early detection and management of sickle cell anemia. Mandatory newborn screening programs in countries like the United States have been pivotal in early diagnosis, leading to better patient outcomes. For instance, the National Institutes of Health (NIH) announced over USD 50 million in funding for gene therapy research targeting sickle cell disease in September 2023, highlighting the emphasis on early detection and innovative treatments.
In Europe, countries such as the UK, France, and Italy have expanded their newborn screening programs, reflecting a growing recognition of the importance of early diagnosis. Public health campaigns, supported by organizations like the French Sickle Cell Disease Association, aim to reduce stigma and promote early detection, further driving the market in these regions.
In the Asia Pacific region, the market is expected to register the fastest CAGR of 12.6% over the forecast period. Countries like India, Pakistan, Bangladesh, and Sri Lanka are witnessing rising cases, particularly in tribal and rural communities. The Indian government has initiated programs to address this issue, focusing on increasing awareness and providing accessible testing in high-prevalence areas.
Technological advancements have also played a crucial role in market growth. High-performance liquid chromatography (HPLC) has emerged as a preferred testing method due to its accuracy and efficiency. Point-of-care tests are gaining traction, offering rapid results and facilitating timely interventions, especially in resource-limited settings.
However, challenges such as high costs associated with advanced diagnostic technologies and limited awareness in low-resource settings may hinder market growth. Efforts to make testing more affordable and accessible are essential to overcome these barriers and ensure early diagnosis and management of sickle cell anemia globally.
Get an In-Depth Research Analysis of the Global Sickle Cell Anemia Testing & Screening Market Size And Forecast [2025-2032]
The global sickle cell anemia testing and screening market has experienced significant growth from 2018 to 2022, with projections indicating a continued upward trajectory from 2023 to 2033. In 2022, the market was valued at approximately USD 832.68 million and is expected to reach USD 943.95 million in 2023. This growth is driven by increased awareness and the implementation of newborn screening programs in various countries.
Looking ahead, the market is projected to grow at a Compound Annual Growth Rate (CAGR) of 13.49%, reaching an estimated USD 2,293.22 million by 2030. Factors contributing to this growth include advancements in diagnostic technologies and a rising global prevalence of sickle cell anemia, particularly in high-risk regions.
STRECK
INC.
BioMedomics Inc.
Laboratory Corporation of America Holdings
Silver Lake Research Corporation
HEMEX HEALTH
Bio-Rad Laboratories
Inc.
PerkinElmer Inc.
Quest Diagnostics
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Sickle Cell Anemia Testing & Screening Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Sickle Cell Anemia Testing & Screening Market
Newborn Screening (12 months and below)
Adult Screening (25 to 60 years)
Other Age Groups (1 to 25 & above 60 years)
Based on Types the Market is categorized into Below types that held the largest Sickle Cell Anemia Testing & Screening market share In 2023.
Hemoglobin Electrophoresis
High-performance Liquid Chromatography (HPLC)
Point-of-Care Tests
Other Tests
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Sickle Cell Anemia Testing & Screening Market Research Analysis
1. Introduction of the Global Sickle Cell Anemia Testing & Screening Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Sickle Cell Anemia Testing & Screening Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Sickle Cell Anemia Testing & Screening Market, By Type
6. Global Sickle Cell Anemia Testing & Screening Market, By Application
7. Global Sickle Cell Anemia Testing & Screening Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Sickle Cell Anemia Testing & Screening Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/